학술논문

Asian Americans & chronic kidney disease in a nationally representative cohort
Document Type
article
Source
BMC Nephrology. 20(1)
Subject
Biomedical and Clinical Sciences
Public Health
Health Sciences
Prevention
Kidney Disease
Clinical Research
Renal and urogenital
Adult
Aged
Albuminuria
Asian
Comorbidity
Creatinine
Diabetes Mellitus
Early Diagnosis
Female
Glomerular Filtration Rate
Humans
Hypertension
Male
Middle Aged
Nutrition Surveys
Obesity
Renal Insufficiency
Chronic
Socioeconomic Factors
Young Adult
Clinical Sciences
Urology & Nephrology
Clinical sciences
Health services and systems
Nursing
Language
Abstract
BackgroundThere is a paucity of specific data on early stages of chronic kidney disease (CKD) among Asian Americans (AAs). The objective of this study was to examine the independent association of Asian race/ethnicity and socio-demographic and co-morbidity factors with markers of early kidney damage, ascertained by ACR levels, as well as kidney dysfunction, ascertained by eGFR levels in a large cross-sectional sample of AAs enrolled in the National Health and Nutrition Examination Survey (NHANES).MethodsSecondary data analyses of the NHANES 2011-2014 data of a nationally representative sample of 5907 participants 18 years and older, US citizens, and of Asian and White race. NHANES data included race (Asian vs. White), as well as other socio-demographic information and comorbidities. Urine albumin-to-creatinine ratio (ACR) categories and estimated glomerular filtration rate (eGFR) were used as indicators for CKD. Descriptive analyses using frequencies, means (standard deviations), and chi-square tests was first conducted, then multivariable logistic regression serial adjustment models were used to examine the associations between race/ethnicity, other socio-demographic factors (age, sex, education), and co-morbidities (obesity, diabetes, hypertension) with elevated ACR levels (A2 & A3 - CKD Stages 3 and 4-5, respectively) as well as reduced eGFR (G3a-G5 and G3b -G5 - CKD Stage 3-5).ResultsAAs were more likely than White participants to have ACR levels > 300 mg/g (A3) (adjusted OR (aOR) (95% CI) 2.77 (1.55, 4.97), p = 0.001). In contrast, adjusted analyses demonstrated that AAs were less likely to have eGFR levels  300 mg/g levels (A3) but lower risk of having eGFR levels